{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:34:00Z","timestamp":1789540440260,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s12185-017-2241-1","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T05:15:35Z","timestamp":1493183735000},"page":"732-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Somatic SETBP1 mutations in myeloid neoplasms"],"prefix":"10.1007","volume":"105","author":[{"given":"Hideki","family":"Makishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"key":"2241_CR1","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","unstructured":"Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368:2059\u201374.","journal-title":"N Engl J Med"},{"key":"2241_CR2","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209\u201321.","journal-title":"N Engl J Med"},{"key":"2241_CR3","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369:2379\u201390.","journal-title":"N Engl J Med"},{"key":"2241_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ng.3742","volume":"49","author":"H Makishima","year":"2017","unstructured":"Makishima H, Yoshizato T, Yoshida K, Sekeres MA, Radivoyevitch T, Suzuki H, et al. Dynamics of clonal evolution in myelodysplastic syndromes. Nat Genet. 2017;49:204\u201312.","journal-title":"Nat Genet"},{"key":"2241_CR5","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Masse A, et al. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360:2289\u2013301.","journal-title":"N Engl J Med"},{"key":"2241_CR6","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/leu.2010.167","volume":"24","author":"H Makishima","year":"2010","unstructured":"Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z, et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia. 2010;24:1799\u2013804.","journal-title":"Leukemia"},{"key":"2241_CR7","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1182\/blood-2011-07-365320","volume":"118","author":"V Grossmann","year":"2011","unstructured":"Grossmann V, Tiacci E, Holmes AB, Kohlmann A, Martelli MP, Kern W, et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood. 2011;118:6153\u201363.","journal-title":"Blood"},{"key":"2241_CR8","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.2731","volume":"45","author":"A Kon","year":"2013","unstructured":"Kon A, Shih LY, Minamino M, Sanada M, Shiraishi Y, Nagata Y, et al. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. Nat Genet. 2013;45:1232\u20137.","journal-title":"Nat Genet"},{"key":"2241_CR9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/leu.2014.25","volume":"28","author":"N Hosono","year":"2014","unstructured":"Hosono N, Makishima H, Jerez A, Yoshida K, Przychodzen B, McMahon S, et al. Recurrent genetic defects on chromosome 7q in myeloid neoplasms. Leukemia. 2014;28:1348\u201351.","journal-title":"Leukemia"},{"key":"2241_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/leu.2014.144","volume":"29","author":"A Kurtovic-Kozaric","year":"2015","unstructured":"Kurtovic-Kozaric A, Przychodzen B, Singh J, Konarska MM, Clemente MJ, Otrock ZK, et al. PRPF8 defects cause missplicing in myeloid malignancies. Leukemia. 2015;29:126\u201336.","journal-title":"Leukemia"},{"key":"2241_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3324\/haematol.2014.120931","volume":"100","author":"D Huang","year":"2015","unstructured":"Huang D, Nagata Y, Grossmann V, Radivoyevitch T, Okuno Y, Nagae G, et al. BRCC3 mutations in myeloid neoplasms. Haematologica. 2015;100:1051\u20137.","journal-title":"Haematologica"},{"key":"2241_CR12","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1038\/leu.2016.212","volume":"30","author":"T Mori","year":"2016","unstructured":"Mori T, Nagata Y, Makishima H, Sanada M, Shiozawa Y, Kon A, et al. Somatic PHF6 mutations in 1760 cases with various myeloid neoplasms. Leukemia. 2016;30:2270\u20133.","journal-title":"Leukemia"},{"key":"2241_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature08240","volume":"460","author":"M Sanada","year":"2009","unstructured":"Sanada M, Suzuki T, Shih LY, Otsu M, Kato M, Yamazaki S, et al. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature. 2009;460:904\u20138.","journal-title":"Nature"},{"key":"2241_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R, et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature. 2011;478:64\u20139.","journal-title":"Nature"},{"key":"2241_CR15","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/leu.2013.179","volume":"27","author":"I Gomez-Segui","year":"2013","unstructured":"Gomez-Segui I, Makishima H, Jerez A, Yoshida K, Przychodzen B, Miyano S, et al. Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies. Leukemia. 2013;27:1943\u20136.","journal-title":"Leukemia"},{"key":"2241_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nm.3751","volume":"21","author":"A Yoda","year":"2015","unstructured":"Yoda A, Adelmant G, Tamburini J, Chapuy B, Shindoh N, Yoda Y, et al. Mutations in G protein beta subunits promote transformation and kinase inhibitor resistance. Nat Med. 2015;21:71\u20135.","journal-title":"Nat Med"},{"key":"2241_CR17","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.3324\/haematol.2015.127985","volume":"100","author":"M Meggendorfer","year":"2015","unstructured":"Meggendorfer M, de Albuquerque A, Nadarajah N, Alpermann T, Kern W, Steuer K, et al. Karyotype evolution and acquisition of FLT3 or RAS pathway alterations drive progression of myelodysplastic syndrome to acute myeloid leukemia. Haematologica. 2015;100:e487\u201390.","journal-title":"Haematologica"},{"key":"2241_CR18","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa1106968","volume":"366","author":"MJ Walter","year":"2012","unstructured":"Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, Chen K, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366:1090\u20138.","journal-title":"N Engl J Med"},{"key":"2241_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.17","author":"T Kim","year":"2017","unstructured":"Kim T, Tyndel MS, Kim HJ, Ahn JS, Choi SH, Park HJ, et al. The clonal origins of leukemic progression of myelodysplasia. Leukemia. 2017; doi:10.1038\/leu.2017.17.","journal-title":"Leukemia"},{"key":"2241_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/leu.2015.129","volume":"30","author":"A Pellagatti","year":"2016","unstructured":"Pellagatti A, Roy S, Di Genua C, Burns A, McGraw K, Valletta S, et al. Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression. Leukemia. 2016;30:247\u201350.","journal-title":"Leukemia"},{"key":"2241_CR21","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1046\/j.1432-1327.2001.02000.x","volume":"268","author":"M Minakuchi","year":"2001","unstructured":"Minakuchi M, Kakazu N, Gorrin-Rivas MJ, Abe T, Copeland TD, Ueda K, et al. Identification and characterization of SEB, a novel protein that binds to the acute undifferentiated leukemia-associated protein SET. Eur J Biochem. 2001;268:1340\u201351.","journal-title":"Eur J Biochem"},{"key":"2241_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nm1393","volume":"12","author":"MG Ott","year":"2006","unstructured":"Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med. 2006;12:401\u20139.","journal-title":"Nat Med"},{"key":"2241_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2141.2006.06410.x","volume":"136","author":"I Panagopoulos","year":"2007","unstructured":"Panagopoulos I, Kerndrup G, Carlsen N, Strombeck B, Isaksson M, Johansson B. Fusion of NUP98 and the SET binding protein 1 (SETBP1) gene in a paediatric acute T cell lymphoblastic leukaemia with t(11;18)(p15;q12). Br J Haematol. 2007;136:294\u20136.","journal-title":"Br J Haematol"},{"key":"2241_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1182\/blood-2009-06-227363","volume":"115","author":"I Cristobal","year":"2010","unstructured":"Cristobal I, Blanco FJ, Garcia-Orti L, Marcotegui N, Vicente C, Rifon J, et al. SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia. Blood. 2010;115:615\u201325.","journal-title":"Blood"},{"key":"2241_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1756-8722-5-48","volume":"5","author":"F Albano","year":"2012","unstructured":"Albano F, Anelli L, Zagaria A, Coccaro N, Casieri P, Minervini A, et al. SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute myeloid leukemia. J Hematol Oncol. 2012;5:48.","journal-title":"J Hematol Oncol"},{"key":"2241_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.stem.2008.06.002","volume":"3","author":"S Goyama","year":"2008","unstructured":"Goyama S, Yamamoto G, Shimabe M, Sato T, Ichikawa M, Ogawa S, et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell. 2008;3:207\u201320.","journal-title":"Cell Stem Cell"},{"key":"2241_CR27","doi-asserted-by":"publisher","first-page":"e198","DOI":"10.1182\/blood-2010-06-292433","volume":"117","author":"H Makishima","year":"2011","unstructured":"Makishima H, Jankowska AM, McDevitt MA, O\u2019Keefe C, Dujardin S, Cazzolli H, et al. CBL, CBLB, TET2, ASXL1, and IDH1\/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia. Blood. 2011;117:e198\u2013206.","journal-title":"Blood"},{"key":"2241_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.2495","volume":"45","author":"R Piazza","year":"2013","unstructured":"Piazza R, Valletta S, Winkelmann N, Redaelli S, Spinelli R, Pirola A, et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet. 2013;45:18\u201324.","journal-title":"Nat Genet"},{"key":"2241_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/ng.2698","volume":"45","author":"H Sakaguchi","year":"2013","unstructured":"Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013;45:937\u201341.","journal-title":"Nat Genet"},{"key":"2241_CR30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ng.2696","volume":"45","author":"H Makishima","year":"2013","unstructured":"Makishima H, Yoshida K, Nguyen N, Przychodzen B, Sanada M, Okuno Y, et al. Somatic SETBP1 mutations in myeloid malignancies. Nat Genet. 2013;45:942\u20136.","journal-title":"Nat Genet"},{"key":"2241_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/ng.581","volume":"42","author":"A Hoischen","year":"2010","unstructured":"Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B, Steehouwer M, et al. De novo mutations of SETBP1 cause Schinzel\u2013Giedion syndrome. Nat Genet. 2010;42:483\u20135.","journal-title":"Nat Genet"},{"key":"2241_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/ajmg.1320010402","volume":"1","author":"A Schinzel","year":"1978","unstructured":"Schinzel A, Giedion A. A syndrome of severe midface retraction, multiple skull anomalies, clubfeet, and cardiac and renal malformations in sibs. Am J Med Genet. 1978;1:361\u201375.","journal-title":"Am J Med Genet"},{"key":"2241_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ejmg.2015.07.004","volume":"58","author":"Y Herenger","year":"2015","unstructured":"Herenger Y, Stoetzel C, Schaefer E, Scheidecker S, Maniere MC, Pelletier V, et al. Long term follow up of two independent patients with Schinzel\u2013Giedion carrying SETBP1 mutations. Eur J Med Genet. 2015;58:479\u201387.","journal-title":"Eur J Med Genet"},{"key":"2241_CR34","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/ajmg.a.36789","volume":"167A","author":"E Carvalho","year":"2015","unstructured":"Carvalho E, Honjo R, Magalhaes M, Yamamoto G, Rocha K, Naslavsky M, et al. Schinzel\u2013Giedion syndrome in two Brazilian patients: report of a novel mutation in SETBP1 and literature review of the clinical features. Am J Med Genet A. 2015;167A:1039\u201346.","journal-title":"Am J Med Genet A"},{"key":"2241_CR35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00381-013-2047-2","volume":"29","author":"JM Ko","year":"2013","unstructured":"Ko JM, Lim BC, Kim KJ, Hwang YS, Ryu HW, Lee JH, et al. Distinct neurological features in a patient with Schinzel\u2013Giedion syndrome caused by a recurrent SETBP1 mutation. Childs Nerv Syst. 2013;29:525\u20139.","journal-title":"Childs Nerv Syst"},{"key":"2241_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1399-0004.2010.01552.x","volume":"79","author":"K Suphapeetiporn","year":"2011","unstructured":"Suphapeetiporn K, Srichomthong C, Shotelersuk V. SETBP1 mutations in two Thai patients with Schinzel\u2013Giedion syndrome. Clin Genet. 2011;79:391\u20133.","journal-title":"Clin Genet"},{"key":"2241_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ejmg.2015.05.006","volume":"58","author":"A Takeuchi","year":"2015","unstructured":"Takeuchi A, Okamoto N, Fujinaga S, Morita H, Shimizu J, Akiyama T, et al. Progressive brain atrophy in Schinzel\u2013Giedion syndrome with a SETBP1 mutation. Eur J Med Genet. 2015;58:369\u201371.","journal-title":"Eur J Med Genet"},{"key":"2241_CR38","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1182\/blood-2016-08-693630","volume":"129","author":"J Gotlib","year":"2017","unstructured":"Gotlib J. How I treat atypical chronic myeloid leukemia. Blood. 2017;129:838\u201345.","journal-title":"Blood"},{"key":"2241_CR39","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/leu.2013.97","volume":"27","author":"RR Laborde","year":"2013","unstructured":"Laborde RR, Patnaik MM, Lasho TL, Finke CM, Hanson CA, Knudson RA, et al. SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia (CMML): independent prognostic impact in CMML. Leukemia. 2013;27:2100\u20132.","journal-title":"Leukemia"},{"key":"2241_CR40","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5355","author":"Y Ouyang","year":"2017","unstructured":"Ouyang Y, Qiao C, Chen Y, Zhang SJ. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Oncotarget. 2017. doi:10.18632\/oncotarget.5355.","journal-title":"Oncotarget"},{"key":"2241_CR41","doi-asserted-by":"crossref","first-page":"28914","DOI":"10.18632\/oncotarget.8016","volume":"7","author":"S Bresolin","year":"2016","unstructured":"Bresolin S, De Filippi P, Vendemini F, D\u2019Alia M, Zecca M, Meyer LH, et al. Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group. Oncotarget. 2016;7:28914\u20139.","journal-title":"Oncotarget"},{"key":"2241_CR42","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ccr3.243","volume":"3","author":"W Hu","year":"2015","unstructured":"Hu W, Wang X, Yang R, Xie Y, Zhang Z, Lu H, et al. A novel mutation of SETBP1 in atypical chronic myeloid leukemia transformed from acute myelomonocytic leukemia. Clin Case Rep. 2015;3:448\u201352.","journal-title":"Clin Case Rep"},{"key":"2241_CR43","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.3324\/haematol.2014.108159","volume":"99","author":"E Fabiani","year":"2014","unstructured":"Fabiani E, Falconi G, Fianchi L, Criscuolo M, Leone G, Voso MT. SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. Haematologica. 2014;99:e152\u20133.","journal-title":"Haematologica"},{"key":"2241_CR44","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4509","author":"E Fabiani","year":"2017","unstructured":"Fabiani E, Falconi G, Fianchi L, Criscuolo M, Ottone T, Cicconi L, et al. Clonal evolution in therapy-related neoplasms. Oncotarget. 2017. doi:10.18632\/oncotarget.4509.","journal-title":"Oncotarget"},{"key":"2241_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ajh.23611","volume":"89","author":"HA Hou","year":"2014","unstructured":"Hou HA, Kuo YY, Tang JL, Chou WC, Yao M, Lai YJ, et al. Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression. Am J Hematol. 2014;89:181\u20136.","journal-title":"Am J Hematol"},{"key":"2241_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-015-0009-y","volume":"4","author":"Y Cui","year":"2015","unstructured":"Cui Y, Tong H, Du X, Li B, Gale RP, Qin T, et al. Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia. Exp Hematol Oncol. 2015;4:14.","journal-title":"Exp Hematol Oncol"},{"key":"2241_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ajh.24332","volume":"91","author":"MM Patnaik","year":"2016","unstructured":"Patnaik MM, Lasho TL, Finke CM, Hanson CA, King RL, Ketterling RP, et al. Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing. Am J Hematol. 2016;91:492\u20138.","journal-title":"Am J Hematol"},{"key":"2241_CR48","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/leu.2013.133","volume":"27","author":"M Meggendorfer","year":"2013","unstructured":"Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, et al. SETBP1 mutations occur in 9% of MDS\/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia. 2013;27:1852\u201360.","journal-title":"Leukemia"},{"key":"2241_CR49","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","volume":"368","author":"JE Maxson","year":"2013","unstructured":"Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368:1781\u201390.","journal-title":"N Engl J Med"},{"key":"2241_CR50","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood-2013-05-500959","volume":"122","author":"J Gotlib","year":"2013","unstructured":"Gotlib J, Maxson JE, George TI, Tyner JW. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood. 2013;122:1707\u201311.","journal-title":"Blood"},{"key":"2241_CR51","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/leu.2013.122","volume":"27","author":"A Pardanani","year":"2013","unstructured":"Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, et al. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia. 2013;27:1870\u20133.","journal-title":"Leukemia"},{"key":"2241_CR52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-014-0077-1","volume":"7","author":"Y Cui","year":"2014","unstructured":"Cui Y, Li B, Gale RP, Jiang Q, Xu Z, Qin T, et al. CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia. J Hematol Oncol. 2014;7:77.","journal-title":"J Hematol Oncol"},{"key":"2241_CR53","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/leu.2014.39","volume":"28","author":"TL Lasho","year":"2014","unstructured":"Lasho TL, Mims A, Elliott MA, Finke C, Pardanani A, Tefferi A. Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib. Leukemia. 2014;28:1363\u20135.","journal-title":"Leukemia"},{"key":"2241_CR54","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.163089","author":"Z Nooruddin","year":"2017","unstructured":"Nooruddin Z, Miltgen N, Wei Q, Schowinsky J, Pan Z, Tobin J, et al. Changes in allele frequencies of CSF3R and SETBP1 mutations and evidence of clonal evolution in a chronic neutrophilic leukemia patient treated with ruxolitinib. Haematologica. 2017. doi:10.3324\/haematol.2016.163089.","journal-title":"Haematologica"},{"key":"2241_CR55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3343\/alm.2015.35.1.118","volume":"35","author":"HW Choi","year":"2015","unstructured":"Choi HW, Kim HR, Baek HJ, Kook H, Cho D, Shin JH, et al. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia. Ann Lab Med. 2015;35:118\u201322.","journal-title":"Ann Lab Med"},{"key":"2241_CR56","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/bjh.12595","volume":"164","author":"N Shiba","year":"2014","unstructured":"Shiba N, Ohki K, Park MJ, Sotomatsu M, Kudo K, Ito E, et al. SETBP1 mutations in juvenile myelomonocytic leukaemia and myelodysplastic syndrome but not in paediatric acute myeloid leukaemia. Br J Haematol. 2014;164:156\u20139.","journal-title":"Br J Haematol"},{"key":"2241_CR57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bjh.12491","volume":"163","author":"M Fernandez-Mercado","year":"2013","unstructured":"Fernandez-Mercado M, Pellagatti A, Di Genua C, Larrayoz MJ, Winkelmann N, Aranaz P, et al. Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression. Br J Haematol. 2013;163:235\u20139.","journal-title":"Br J Haematol"},{"key":"2241_CR58","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/leu.2013.35","volume":"27","author":"F Damm","year":"2013","unstructured":"Damm F, Itzykson R, Kosmider O, Droin N, Renneville A, Chesnais V, et al. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias. Leukemia. 2013;27:1401\u20133.","journal-title":"Leukemia"},{"key":"2241_CR59","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/leu.2014.125","volume":"28","author":"MM Patnaik","year":"2014","unstructured":"Patnaik MM, Itzykson R, Lasho TL, Kosmider O, Finke CM, Hanson CA, et al. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients. Leukemia. 2014;28:2206\u201312.","journal-title":"Leukemia"},{"key":"2241_CR60","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/leu.2014.301","volume":"29","author":"D Inoue","year":"2015","unstructured":"Inoue D, Kitaura J, Matsui H, Hou HA, Chou WC, Nagamachi A, et al. SETBP1 mutations drive leukemic transformation in ASXL1-Mutated MDS. Leukemia. 2015;29:847\u201357.","journal-title":"Leukemia"},{"key":"2241_CR61","doi-asserted-by":"publisher","first-page":"43113","DOI":"10.1038\/srep43113","volume":"7","author":"F Xu","year":"2017","unstructured":"Xu F, Wu LY, He Q, Wu D, Zhang Z, Song LX, et al. Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes. Sci Rep. 2017;7:43113.","journal-title":"Sci Rep"},{"key":"2241_CR62","doi-asserted-by":"crossref","first-page":"14251","DOI":"10.18632\/oncotarget.7350","volume":"7","author":"R Kanagal-Shamanna","year":"2016","unstructured":"Kanagal-Shamanna R, Luthra R, Yin CC, Patel KP, Takahashi K, Lu X, et al. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS. Oncotarget. 2016;7:14251\u20138.","journal-title":"Oncotarget"},{"key":"2241_CR63","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/bjh.13355","volume":"171","author":"V Adema","year":"2015","unstructured":"Adema V, Larrayoz MJ, Calasanz MJ, Palomo L, Patino-Garcia A, Agirre X, et al. Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations. Br J Haematol. 2015;171:137\u201341.","journal-title":"Br J Haematol"},{"key":"2241_CR64","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3892\/ol.2015.3485","volume":"10","author":"O Altangerel","year":"2015","unstructured":"Altangerel O, Cao S, Meng J, Liu P, Haiyan G, Xu Y, et al. Chronic neutrophilic leukemia with overexpression of EVI-1, and concurrent CSF3R and SETBP1 mutations: a case report. Oncol Lett. 2015;10:1694\u2013700.","journal-title":"Oncol Lett"},{"key":"2241_CR65","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/leu.2013.145","volume":"27","author":"F Thol","year":"2013","unstructured":"Thol F, Josef Suchanek K, Koenecke C, Stadler M, Platzbecker U, Thiede C, et al. SETBP1 mutation analysis in 944 patients with MDS and AML. Leukemia. 2013;27:2072\u20135.","journal-title":"Leukemia"},{"key":"2241_CR66","doi-asserted-by":"publisher","first-page":"e0171608","DOI":"10.1371\/journal.pone.0171608","volume":"12","author":"LH Shou","year":"2017","unstructured":"Shou LH, Cao D, Dong XH, Fang Q, Wu Y, Zhang Y, et al. Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: a meta-analysis. PLoS One. 2017;12:e0171608.","journal-title":"PLoS One"},{"key":"2241_CR67","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1182\/blood-2014-09-601690","volume":"125","author":"E Stieglitz","year":"2015","unstructured":"Stieglitz E, Troup CB, Gelston LC, Haliburton J, Chow ED, Yu KB, et al. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia. Blood. 2015;125:516\u201324.","journal-title":"Blood"},{"key":"2241_CR68","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/leu.2015.200","volume":"30","author":"BA Vishwakarma","year":"2016","unstructured":"Vishwakarma BA, Nguyen N, Makishima H, Hosono N, Gudmundsson KO, Negi V, et al. Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development. Leukemia. 2016;30:200\u20138.","journal-title":"Leukemia"},{"key":"2241_CR69","doi-asserted-by":"crossref","first-page":"86300","DOI":"10.18632\/oncotarget.13383","volume":"7","author":"N Nguyen","year":"2016","unstructured":"Nguyen N, Vishwakarma BA, Oakley K, Han Y, Przychodzen B, Maciejewski JP, et al. Myb expression is critical for myeloid leukemia development induced by Setbp1 activation. Oncotarget. 2016;7:86300\u201312.","journal-title":"Oncotarget"},{"key":"2241_CR70","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1182\/blood-2011-10-388710","volume":"119","author":"K Oakley","year":"2012","unstructured":"Oakley K, Han Y, Vishwakarma BA, Chu S, Bhatia R, Gudmundsson KO, et al. Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10. Blood. 2012;119:6099\u2013108.","journal-title":"Blood"},{"key":"2241_CR71","doi-asserted-by":"publisher","first-page":"e1006683","DOI":"10.1371\/journal.pgen.1006683","volume":"13","author":"R Acuna-Hidalgo","year":"2017","unstructured":"Acuna-Hidalgo R, Deriziotis P, Steehouwer M, Gilissen C, Graham SA, van Dam S, et al. Overlapping SETBP1 gain-of-function mutations in Schinzel\u2013Giedion syndrome and hematologic malignancies. PLoS Genet. 2017;13:e1006683.","journal-title":"PLoS Genet"}],"updated-by":[{"DOI":"10.1007\/s12185-021-03236-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000}}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2241-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-017-2241-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-017-2241-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T19:45:15Z","timestamp":1719171915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-017-2241-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["2241"],"URL":"https:\/\/doi.org\/10.1007\/s12185-017-2241-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]},"assertion":[{"value":"4 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12185-021-03236-1","URL":"https:\/\/doi.org\/10.1007\/s12185-021-03236-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}